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Background
Exercise intolerance is a common feature of many non-
cardiac and non-respiratory diseases. The causes are often
multifactorial and include secondary cardiac-respiratory
dysfunction, as well as skeletal muscle abnormalities.
Unfortunately, it is difficult to determine the exact cause
using conventional cardiopulmonary exercise testing
(CPET). Therefore, we have developed MR augmented
CPET that allows simultaneous evaluation of cardiac out-
put and tissue oxygen extraction in addition to conven-
tional CPET measures. To demonstrate the utility of this
technique we performed MR-CPET on patients with sickle
cell disease (SCD). The aim of this study was to demon-
strate that MR-CPET could be used to define the physio-
logical factors associated with their poorly understood
exercise intolerance.
Methods
14 patients with homozygous sickle cell disease (age: 30-
41) and 14 healthy volunteers (age: 25-37) underwent
MR-CPET. Exercise was performed on MR-compatible
ergometer (Lode, Groningen, The Netherlands) and
minute ventilation (VE), oxygen consumption (VO2),
and carbon dioxide production (VCO2) were assessed
using a commercial respiratory gas analyser (Ultima,
MedGraphics, St. Paul, USA) with modified sampling
tube that was MR compatible. Aortic flow was simulta-
neously continuously measured using a previously vali-
dated real-time UNFOLD-SENSE spiral PCMR
sequence. MR data was used to derive cardiac output
(CO), heart rate (HR) and stroke volume (SV) curves
during exercise. Arteriovenous oxygen content gradient
(AVO2) curves (a measure of tissue oxygen extraction)
were calculated by dividing the VO2 and CO curves.
Results
All participants completed exercise with no adverse out-
come including the sickle group. MR-CPET measures at
rest and exercise are shown in table 1. The main finding
was that peak VO2 was significantly lower in patients
(fig. 1a). This was partly driven by a reduced CO
response (fig. 1b) in SCD patients, due to a lower peak
heart rate. However, linear regression analysis demon-
strated that reduced AVO2 response (fig. 1c) was the
main driver of reduced peak VO2 (p-0.018) in patients.
Conclusions
Using MR-CPET we have been able to show for the first
time that exercise intolerance in SCD is due to reduced
skeletal muscle oxygen extraction. This may be due to vas-
cular network rarefaction, muscle fibrosis, or reduced mito-
chondrial function; all of which have been demonstrated in
histology specimens in SCD. Without simultaneous CO
measures it is would not have been possible to demonstrate
the importance of reduced tissue extraction. This demon-
strates the power of MR-CPET and we believe this techni-
que could aid in better understanding of exercise
intolerance and possibly better therapeutic interventions.
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Table 1 Resting and peak values during MR-CPET
Variable Normal Mean (range) Disease Mean (range) P-value
Resting VO2, Lmin-1 0.210 (0.17- 0.25) 0.231 (0.19-0.27) 0.38
Peak VO2, Lmin-1 1.1 (0.9- 1.3) 0.7 (0.56- 0.76) 0 < 0.001**
Resting cardiac output, Lmin-1 6.7 (5.9-7.5) 8.1 (7.1-9.2) < 0.05*
Peak cardiac output, Lmin-1 13 (12-14) 12 (11-13) < 0.05*
Resting stroke volume, mlbeat-1 98 (84-111) 109 (98-119) 0.17
Peak Stroke volume, mlbeat-1 101 (81-120) 116 (105- 27) 0.16
Resting heart rate, bpm 66 (56-77) 77 (72-81) 0.067
Max heart rate, bpm 138 (124-152) 120 (111-129) < 0.05*
Resting tissue extraction, mlO2ml-1blood 0.31 (0.26-0.35) 0.28 (0.24-0.32) 0.34
Peak tissue extraction, mlO2ml-1blood 0.90 (0.79-1.02) 0.51 (0.43- 0.59) < 0.001**
Figure 1 (a) Oxygen consumption (b) Cardiac Output and (c)
Tissue extraction during exercise.
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